Trevi Therapeutics Cash Flow Statement (2018-2026) | TRVI

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-9.79M-7.25M-8.52M-7.33M-8.05M-8.27M-5.50M-6.40M-7.14M-7.70M-7.82M-10.90M-12.35M-13.24M-11.41M-10.34M-12.30M-11.80M-8.32M-13.19M
Depreciation and Depletion (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.74M0.54M0.54M0.74M0.52M0.57M0.50M0.58M0.53M0.53M0.53M0.72M1.13M0.82M0.92M1.21M1.38M1.24M1.35M2.19M
Gains from Investment Securities (Quarter)
3.20M1.47M2.93M0.00M4.14M4.14M4.45M5.36M1.56M0.03M0.03M7.82M0.03M0.46M0.21M0.01M4,336.99M3.18M
Non-cash Items (Quarter)
1.39M1.30M1.30M1.49M2.01M2.11M2.20M2.46M2.50M2.61M0.69M3.26M3.49M3.58M11.67M4.23M5.11M5.02M5.18M5.92M
Cash from Operations (Quarter)
-7.90M-7.24M-6.23M-7.09M-6.18M-8.58M-6.33M-8.20M-9.88M-7.28M-6.36M-10.47M-8.68M-9.56M-9.55M-13.48M-10.10M-10.88M-7.63M-16.69M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.03M0.73M0.67M-0.53M1.63M-1.40M0.12M0.60M0.35M-0.61M0.40M0.38M0.30M0.56M0.43M
Amortization of Deferred Charges (Quarter)
0.15M0.15M0.16M0.15M0.14M0.12M0.10M0.08M0.10M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.03M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.03M0.03M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
2.69M-1.25M0.61M-1.11M2.05M-1.47M0.54M-0.91M-0.59M-0.17M0.63M0.29M-0.62M0.13M1.80M-1.99M1.55M-0.28M0.12M-1.48M
Change in Accured Expenses (Quarter)
-0.76M0.09M0.56M0.01M0.34M0.31M-1.30M-0.06M-0.73M0.82M0.02M-0.94M2.02M2.20M-0.71M-1.50M0.50M0.14M-0.56M-1.07M
Other Working Capital Changes (Quarter)
0.00M0.18M-0.46M-0.42M0.00M0.04M0.02M0.00M0.21M0.23M-0.09M-0.58M0.07M0.07M0.08M0.60M0.01M-0.16M
Investing Activities
Capital Expenditures (Quarter)
0.12M0.06M0.04M0.02M0.02M0.01M0.01M0.10M
Change in Acquisitions & Divestments (Quarter)
17.00M18.00M19.68M18.00M13.82M22.17M12.75M20.72M21.33M17.59M14.50M20.68M23.79M25.55M
Cash from Investing Activities (Quarter)
-4.85M-48.31M8.96M19.64M17.98M12.85M-8.09M2.77M7.67M-23.87M-9.95M-2.61M-50.94M-30.61M16.96M
Financing Activities
Other financing activities (Quarter)
0.30M0.10M0.04M-0.02M0.01M0.01M1.68M-1.45M14.15M0.22M0.37M0.22M
Cash from Financing Activities (Quarter)
2.75M0.13M13.74M-0.62M55.98M55.30M0.65M-1.70M-7.66M1.51M-0.05M-0.03M5.07M4.98M51.47M8.71M110.39M1.63M0.28M0.22M
Additional items
Change in Cash (Quarter)
-5.14M-7.11M7.51M-7.72M-4.42M41.88M-53.98M-0.94M2.10M12.21M6.43M-18.59M-0.85M3.09M18.05M-14.72M97.68M-60.19M-37.95M0.50M
Free Cash Flow (Quarter)
-7.90M-7.24M-6.23M-7.09M-6.18M-8.58M-6.45M-8.25M-9.91M-7.30M-6.38M-10.47M-8.68M-9.56M-9.56M-13.48M-10.10M-10.89M-7.63M-16.79M
Net Cash Flow (Quarter)
-5.14M-7.11M7.51M-7.72M49.80M41.88M-53.98M-0.94M2.10M12.21M6.43M-18.59M-0.85M3.09M18.05M-14.72M97.68M-60.19M-37.95M0.50M